Hematologist-oncologist Mateo Mejia Saldarriaga, MD, combines clinical care with research aimed at helping patients with ...

For decades, the diagnosis of multiple myeloma required evidence of end-organ damage characterized by myeloma-defining events ...

The study highlights the importance of including patient self-assessment—and not just clinician assessment—when planning ...

A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients ...

While there is no cure for multiple myeloma, increased awareness about the symptoms can be the key to timely diagnosis and ...

Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment ...

CAR-T therapy for myeloma faces challenges in early-line use due to accessibility, eligibility criteria and long wait times, ...

More than half of patients recently diagnosed with lymphoma or myeloma had clinically significant symptoms of anxiety or ...

Alfie Swain was diagnosed with multiple myeloma — a type of blood cancer — in August 2020, after discovering a tumour on his ...

Dean Berhaupt has become the first patient to receive CAR T-cell therapy in Albany, marking a significant milestone for ...

Autologous stem cell transplant is an advanced treatment method that rapidly restores the patient's hematopoietic system ...

During a live event, Patrick Moore, MD, discussed the superior efficacy with ide-cel vs standard care in relapsed/refractory ...